ANTIBODIES - Patent 0789713

(19)

(11)

EP 0 789 713 A1

(12)

(43)	Date of publication:
	20.08.1997 Bulletin 1997/34

(21)	Application number: 95936025.0

(22)	Date of filing: 03.11.1995

(51)

International Patent Classification (IPC):

C12N 15/ 09^{( . )}
A61K 38/ 43^{( . )}
A61K 47/ 48^{( . )}
A61K 51/ 10^{( . )}
A61P 11/ 00^{( . )}
A61P 15/ 00^{( . )}
A61P 25/ 00^{( . )}
A61P 35/ 00^{( . )}
A61P 37/ 00^{( . )}
A61P 43/ 00^{( . )}
C07K 16/ 28^{( . )}
C12P 21/ 08^{( . )}

A61K 38/ 00^{( . )}
A61K 39/ 395^{( . )}
A61K 51/ 00^{( . )}
A61P 3/ 08^{( . )}
A61P 13/ 02^{( . )}
A61P 17/ 00^{( . )}
A61P 29/ 00^{( . )}
A61P 35/ 02^{( . )}
A61P 37/ 06^{( . )}
C07K 16/ 00^{( . )}
C07K 19/ 00^{( . )}

(86)	International application number:
	PCT/GB1995/002585

(87)	International publication number:
	WO 1996/014339 (17.05.1996 Gazette 1996/22)

(84)	Designated Contracting States:
	AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE
	Designated Extension States:
	LT LV SI

(30)

Priority:

05.11.1994 GB 19940022383

(71)	Applicant: THE WELLCOME FOUNDATION LIMITED
	Greenford, Middlesex UB6 0NN (GB)

(72)	Inventors:
	KULL, Frederick, Charles, Jr. Durham, NC 27707 (US) FLING, Mary, Elizabeth Durham, NC 27707 (US) STIMMEL, Julie, Beth Durham, NC 27713 (US)

(74)	Representative: Stott, Michael John, et al
	Glaxo Wellcome plc, Glaxo Wellcome House, Berkeley Avenue Greenford, Middlesex UB6 0NN Greenford, Middlesex UB6 0NN (GB)

(54)	ANTIBODIES